会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 91. 发明授权
    • Patient sensory response evaluation for neuromodulation efficacy rating
    • 患者感觉反应评估神经调节功效评定
    • US07206632B2
    • 2007-04-17
    • US10768352
    • 2004-01-30
    • Gary W. King
    • Gary W. King
    • A61B5/00
    • A61N1/36021A61N1/36025A61N1/36071G06F19/00G06F19/3481
    • The invention is directed to a technique for rating neuromodulation efficacy based on evaluation of the response of the patient to sensory stimuli with and without delivery of neuromodulation therapy. In addition, the invention may provide a system capable of delivering sensory stimuli on a quantitative basis in a coordinated manner with delivery of neuromodulation therapy. A device programmer may provide a platform for controlling delivery of the sensory stimuli, delivery of neuromodulation therapy, and generation of rating information for neuromodulation efficacy based on patient sensory response to the stimuli. In operation, the programmer controls application of selected sensory stimuli to the patient's body and records the patient's verbal or physiological responses to the stimuli. This invention can be used to be a diagnostic or prognostic test that a given neuromodulation therapy, such as neurostimulation or drug delivery, is and will be successful.
    • 本发明涉及一种用于评估神经调节功效的技术,其基于评估患者对具有和不具有神经调节治疗的神经调节治疗的感觉刺激的反应。 此外,本发明可以提供能够以协调的方式与神经调节治疗的递送在定量基础上递送感觉刺激的系统。 设备程序员可以提供用于控制感觉刺激的递送,神经调节治疗的递送以及基于患者对刺激的感觉反应来产生神经调节功效的评分信息的平台。 在操作中,程序员控制所选择的感觉刺激对患者身体的应用,并将患者的口头或生理反应记录到刺激物上。 本发明可以用于诊断或预后测试,给定的神经调节治疗,例如神经刺激或药物递送,并且将是成功的。
    • 92. 发明授权
    • Method and apparatus for gauging severity of myocardial ischemic episodes
    • 测量心肌缺血发作严重程度的方法和装置
    • US07066891B2
    • 2006-06-27
    • US10325076
    • 2002-12-20
    • Robert W. StadlerSteven N. LuGary W. KingThomas R. Moore
    • Robert W. StadlerSteven N. LuGary W. KingThomas R. Moore
    • A61B5/02
    • A61B5/0452A61N1/362G06F19/00
    • An implantable medical device (IMD) for gauging the severity of ischemia in a patient's heart includes a data collection module configured to receive data about the patient's heart, a data processing module configured to process the data to identify an episode of ischemia in the patient and to determine if the episode is stable or unstable, and a reporting module configured to provide an alarm to the patient if the episode is unstable. A method executable by an implantable medical device to detect ischemia in a human heart suitably includes the steps of receiving data about the heart at the implantable medical device, processing the data within the implantable medical device to determine the severity of ischemia, and providing a response from the implantable medical device to the patient if ischemia is indicated.
    • 用于测量患者心脏的严重程度的可植入医疗装置(IMD)包括:数据收集模块,被配置为接收关于患者心脏的数据;数据处理模块,被配置为处理所述数据以识别患者的局部缺血发作;以及 以确定剧集是否稳定或不稳定,并且报告模块被配置为如果发作不稳定则向患者提供警报。 可植入医疗装置可检测人心脏缺血的方法适当地包括以下步骤:在可植入医疗装置处接收关于心脏的数据,处理可植入医疗装置内的数据以确定局部缺血的严重性,并提供反应 从可植入的医疗装置到患者,如果指示缺血。